3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Prostatic Neoplasms
5
Breast Neoplasms
4
Ovarian Neoplasms
3
Triple Negative Breast Neoplasms
2
Polycystic Ovary Syndrome
2
Pancreatic Neoplasms
2
Overweight
2
Obesity
2
Multiple Myeloma
2
Motor Activity
2
Melanoma
2
Lung Neoplasms
2
Glioblastoma
2
Colorectal Neoplasms
2
Weight Loss
1
Uveal Melanoma
1
Stage IV Breast Cancer AJCC v6 and v7
1
Smoking Cessation
1
Quality of Life
1
Postoperative Complications
1
Patient Compliance
1
Neoplasms
1
Metabolic Syndrome
1
Localized Prostate Carcinoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypothalamic Neoplasms
1
Healthy Diet
1
Glioma
1
Interventions
Nivolumab
11
pembrolizumab
10
Ipilimumab
9
Cyclophosphamide
6
tebentafusp
5
Interleukin-2
4
Blood Specimen Collection
4
fludarabine phosphate
3
fludarabine
3
Specimen Handling
3
Radiosurgery
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
relatlimab
2
lenvatinib
2
cemiplimab
2
binimetinib
2
aflibercept
2
Surveys and Questionnaires
2
Dacarbazine
2
Crizotinib
2
Carmustine
2
Biopsy
2
ulixertinib
1
trametinib
1
sargramostim
1
ruxolitinib
1
omipalisib
1
olaparib
1
lifileucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Diet Therapy
×
1 year
×
Clear all
NCT04645680
2026-01-30
DIET
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
50 enrolled